Text Size

Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile

This study is not yet open for participant recruitment.
Verified November 2011 by Universidad de Valparaiso
Sponsor:
Information provided by (Responsible Party):
Carolina San Martin, Universidad de Valparaiso
ClinicalTrials.gov Identifier:
NCT01483794
First received: November 23, 2011
Last updated: November 30, 2011
Last verified: November 2011
History of Changes
  Purpose

This is an observational study looking at the characteristics of patients consulting for genital warts in the first semester 2010 at the public sexual health clinic of Valparaiso, Chile. The objectives are: to have an epidemiological profile, estimating cost of the disease for the health system and the patient and analyzing possible psychosocial consequences of the condition for the patients.


Condition
Condylomata Acuminata

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Genital Warts: Studies for Establishing Epidemiological Profile, Psychosocial Consequences and Costs of Disease in Attendants to the Sexual Health Clinic of the Public Health Service of Valparaiso and San Antonio, Chile.

Resource links provided by NLM:

MedlinePlus related topics: Genital Warts Warts
U.S. FDA Resources

Further study details as provided by Universidad de Valparaiso:

Primary Outcome Measures:
  • Number of Participants with altered psychosocial tests as a Measure of impact of presenting genital warts. [ Time Frame: one year ] [ Designated as safety issue: No ]
    The psychosocial consequences of presenting genital warts will be assessed.


Estimated Enrollment: 60
Study Start Date: November 2011
Estimated Study Completion Date: April 2012
Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Genital warts treated
Patients that have had treatment on their genital warts
Genital warts on treatment
Patients currently being treated for genital warts

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients attending the public sexual health clinic of Valparaiso, Chile

Criteria

Inclusion Criteria:

  • Men and women 18 years of age or older
  • Having being diagnosed with genital warts
  • Consulting the sexual health clinic only for genital warts
  • Patients accepting to be included in the study

Exclusion Criteria:

  • Immunodeficiency
  • HIV positive
  • Having being diagnosed with cancer or pre-cancerous lesions
  • Pregnancy
  • Presenting a sexual transmissible infection other than genital warts.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01483794

Contacts
Contact: Heraldo S Povea, MD +56-9-91629388 heraldopoveapacci@gmail.com
Contact: Carolina San Martin, MD +56-9-92895478 caroladc@hotmail.com

Locations
Chile
Sexual Health Clinic Not yet recruiting
Valparaiso, Quinta Region, Chile, V
Principal Investigator: Carolina San Martin, MD            
Sexual Health Clinic, Not yet recruiting
Valparaiso, Quinta Region, Chile, V
Contact: Carolina San Martin, MD     +56-9-92895478     caroladc@hotmail.com    
Contact: Heraldo S Povea, MD     +56-9-91629388     heraldopoveapacci@gmail.com    
Principal Investigator: Carolina San Martin, MD            
Sponsors and Collaborators
Universidad de Valparaiso
Investigators
Principal Investigator: Carolina San Martin, MD University of Valparaiso, Chile
  More Information

No publications provided

Responsible Party: Carolina San Martin, Principal investigator, Universidad de Valparaiso
ClinicalTrials.gov Identifier: NCT01483794     History of Changes
Other Study ID Numbers: CondValpo2011, 1501
Study First Received: November 23, 2011
Last Updated: November 30, 2011
Health Authority: Chile: Ministry of Health

Keywords provided by Universidad de Valparaiso:
genital warts

Additional relevant MeSH terms:
Condylomata Acuminata
Warts
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
 Sexually Transmitted Diseases
Skin Diseases, Viral
Tumor Virus Infections
Skin Diseases, Infectious
Skin Diseases

ClinicalTrials.gov processed this record on May 19, 2013